Deputy Chief Physician、Associate Professor
Research Interests: Interventional treatment of coronary heart disease and structural heart disease; intravascular luminal imaging and functional assessment and intervention; basic research and clinical translation of cardiovascular disease.
Ding Song, M.D., Ph.D., is Deputy Chief Physician of Department of Cardiology, Renji Hospital and Master's Supervisor. He is currently a member of Youth Committee of Cardiovascular Physicians Branch of Chinese Medical Doctor Association and a Member of the Coronary Imaging and Physiology Group of the Chinese Medical Association Cardiovascular Branch. He has been a visiting scholar at AMBROISE PARE Hospital affiliated to Université Paris Descartes and the Cardiovascular and Pulmonary hospitals affiliated to Université Claude Bernard Lyon 1. In recent years, he has published more than 20 SCI papers as the first author or corresponding author. And he has presided over more than 10 projects related to cardiovascular diseases, including the General Program of National Natural Science Foundation of China and Youth Fund Project of National Natural Science Foundation of China. His research achievements have been awarded the second prize of Science and Technology Progress Award of the Ministry of Education (the third finisher) and the second prize of the Chinese Medical Science and Technology Award (the third finisher).He also has been awarded “Outstanding Academic Leader (Youth)” by Shanghai Science and Technology Commission, “Outstanding Young Medical Talent” by Shanghai Municipal Health Commission, “Shanghai Talent Development Fund” by Shanghai Municipal Human Resources and Social Security Bureau, and “the Apricot Grove Award “ by Shanghai Jiao Tong University School of Medicine.
Inhomogeneous Distribution of Regional Myocardial Work Efficiency Predicts Early Left Ventricular Remodeling After Acute Anterior Myocardial Infarction Treated With Primary Percutaneous Intervention. Front Cardiovasc Med. 2022 Jul 27;9:922567. doi: 10.3389/fcvm.2022.922567. eCollection 2022. (Corresponding author)
Pericoronary Fat Attenuation Index Is Associated With Vulnerable Plaque Components and Local Immune-Inflammatory Activation in Patients With Non-ST Elevation Acute Coronary Syndrome. J Am Heart Assoc. 2022 Jan 18;11(2):e022879. (Corresponding author)
Disulfiram protects against abdominal aortic aneurysm by ameliorating vascular smooth muscle cells pyroptosis. Cardiovasc Drugs Ther. 2022 Jun 20. doi: 10.1007/s10557-022-07352-w. Online ahead of print. (Corresponding author)
NR1D1 Deletion Induces Rupture-Prone Vulnerable Plaques by Regulating Macrophage Pyroptosis via the NF- κ B/NLRP3 Inflammasome Pathway. Oxid Med Cell Longev. 2021 Dec 16;2021:5217572. doi: 10.1155/2021/5217572. eCollection 2021. (Corresponding author)
Elevated Serum Levels of Soluble ST2 Are Associated With Plaque Vulnerability in Patients With Non-ST-Elevation Acute Coronary Syndrome. Front Cardiovasc Med. 2021 Jul 22;8:688522. doi: 10.3389/fcvm.2021.688522. eCollection 2021. (Corresponding author)
Sequential vessel segmentation via deep channel attention network. Neural Netw. 2020 Aug;128:172-187.(Co-first author)
Novel application of quantitative flow ratio for predicting microvascular dysfunction after ST-segment-elevation myocardial infarction. Catheter Cardiovasc Interv. 2020 Feb;95 Suppl 1:624-632. (Corresponding author)
Melatonin Stabilizes Rupture-Prone Vulnerable Plaques via Regulating Macrophage Polarization in a Nuclear Circadian Receptor RORα-Dependent Manner. J Pineal Res. 2019 Apr 22:e12581.(First author)
Intracoronary infusion of alprostadil and nitroglycerin with targeted perfusion microcatheter in STEMI patients with coronary slow flow phenomenon. Int J Cardiol. 2018 Aug 15;265:6-11. (Corresponding author)
Novel protective role of the circadian nuclear receptor retinoic acid-related orphan receptor-α in diabetic cardiomyopathy. J Pineal Res. 2017 Apr;62(3), e12378. (Co-first author)
Nuclear receptor retinoid-related orphan receptor α deficiency exacerbates high-fat diet-induced cardiac dysfunction despite improving metabolic abnormality. Biochim Biophys Acta. 2017 Aug;1863(8):1991-2000. (Co-first author)